|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Revenues | |||||
| License and Development Services Revenue | |||||
| License and development services | |||||
| Other Collaboration Revenue | |||||
| Total revenues | |||||
| Operating expenses: | |||||
| Research and development (Includes $25, ($39) and ($110) payments to/(from) a related party) | |||||
| General and administrative (Includes $5, $2 and $— payments to a related party) | |||||
| Impairment of long-lived assets (see Note 14, Leases) | |||||
| Total operating expenses | |||||
| Loss from operations | |||||
| Non-operating income (expense): | |||||
| Interest and other income, net | |||||
| Interest expense | |||||
| Total non-operating income, net | |||||
| Loss before income taxes | |||||
| Income tax expense | |||||
| Net loss | |||||
| Other comprehensive income (loss) | |||||
| Comprehensive income (loss) | |||||
| Net loss per share, basic (in dollars per share) | |||||
| Net loss per share, diluted (in dollars per share) | |||||
| Shares used to compute net loss per share, basic (in shares) | |||||
| Shares used to compute net loss per share, diluted (in shares) | |||||
Loading...
